We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




MEDICA and COMPAMED 2022 Planning Enters Next Stage, Exhibitors Can Still Register

By LabMedica International staff writers
Posted on 21 Jul 2022
Print article
Image: Current exhibitor registrations indicate that participation at MEDICA and COMPAMED will surpass last year’s results (Photo courtesy of Messe Düsseldorf)
Image: Current exhibitor registrations indicate that participation at MEDICA and COMPAMED will surpass last year’s results (Photo courtesy of Messe Düsseldorf)

The planning for the world’s leading medical trade fair MEDICA 2022 as well as for COMPAMED 2022, the No. 1 trade fair for suppliers of the medical technology industry, organized by Messe Düsseldorf (Düsseldorf, Germany), has entered the next stage. The current number of exhibitor registrations indicates that participation will surpass last year’s results (MEDICA 2021: 3,033; COMPAMED 2021: 490). Exhibitors can still register online for all segments at MEDICA and COMPAMED which will take place concurrently from November 14 – 17, 2022 at the fairgrounds in Düsseldorf, Germany.

In their globally unique combination, MEDICA 2022 and COMPAMED 2022 will again reflect the entire medical technology value and process chains and present a comprehensive range of medical products, devices and instruments. In 2021, 46,000 trade visitors took part in both events (73% international participation). The focus segments of the MEDICA trade fair are: Laboratory Technology and Diagnostics, Medical Technology and Electromedicine (Imaging and Diagnostics/ Medical Equipment and Devices), Consumer Goods and Consumables, Physiotherapy and Orthopedic Technology, and IT Systems and IT Solutions.

For years, startups from all countries have always participated in MEDICA and COMPAMED in large numbers, both with their own stands and as part of joint stands. The MEDICA START-UP PARK offers an attractive opportunity for participation, especially for first-time exhibitors. In addition to booth presentations, start-ups and scale-ups (companies in the next stage of development) will again provide interesting insights into their current projects in various pitch and presentation formats. For example, the MEDICA DISRUPT sessions, the 11th MEDICA START-UP COMPETITION and the 14th Healthcare Innovation World Cup will all be program highlights at the MEDICA CONNECTED HEALTHCARE FORUM. Overall, about 120 speakers and more than 100 startups will be on hand to discuss digital innovations for mobile and connected healthcare of the future.

Further forums integrated into the individual thematic segments of the trade fair provide a connection to the product innovations and best practices of their application in everyday medical practice. In addition to the MEDICA CONNECTED HEALTHCARE FORUM, these include the MEDICA HEALTH IT FORUM, the MEDICA TECH FORUM, the MEDICA LABMED FORUM and the MEDICA ECON FORUM. The MEDICA conference program also provides a content link to the trend topics of the market and the trade fair. An example is the 45th German Hospital Day, a leading event for the top management of German hospitals, which this year will be held face-to-face again. Two other (English language) conferences will address a mainly international audience: the Conference on Disaster and Military Medicine DiMiMED, and the MEDICA MEDICINE + SPORTS CONFERENCE for the international professional sports medicine and sports science sector.

In order to keep up to date with trends in the preliminary development or manufacturing stages of the medical technology industry, COMPAMED is and remains the must-attend event. This is where supplier companies present a wealth of high-tech and service solutions. Components, microsystems technology, materials processing and coatings, additive manufacturing/ 3D printing, manufacturing technology and machines, packaging and services are key segments that are also reflected by the programs of the two integrated specialist forums: The COMPAMED HIGH-TECH FORUM organized by the IVAM Microtechnology Association and the COMPAMED SUPPLIERS FORUM managed by the trade publication Devicemed. Demand for micro components and processes in the context of digitization and patient-centered diagnostics remains strong since they key to ultra-precise manufacturing and the foundation for lightweight, portable and interconnected devices.

“The medical technology industry right now needs MEDICA and COMPAMED as strong platforms for international exchange, cooperation and business. Because the market is in flux. In certain areas, the pandemic is causing increased demand, for example in point-of-care diagnostics. In addition, companies are seeing an increasing necessity to work jointly with their supply and manufacturing partners to ensure delivery capacity during a time of sharply rising prices and scarce components,” said Christian Grosser, Director Health & Medical Technologies at Messe Düsseldorf. “International networking also helps to open up new markets. You can broaden the base for your own business, while alleviating the effects of obstacles, uncertainties or even sanctions that may apply to certain national markets.”

Related Links:
Messe Düsseldorf

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Silver Member
Fixed Speed Tube Rocker
GTR-FS
New
Hemoglobin/Haptoglobin Assay
IDK Hemoglobin/Haptoglobin Complex ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.